The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis

The Effect of Tang Ning Tongluo Formula, a Traditional Chinese Miao Medicine, in Type 2 Diabetics: A Retrospective Clinical Analysis

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02174042

Enrollment

120

Registered

2014-06-25

Start date

2014-03-31

Completion date

2014-09-30

Last updated

2014-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Disorders and Administration Site Conditions

Brief summary

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule.

Detailed description

The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule,a traditional Chinese Miao medicine, in Type 2 Diabetics.

Interventions

DRUGTangning Tongluo Capsule

Taken drugs 3 times a day, with each time 3 grains

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

1. diagnosis of type 2 diabetes for more than one year. 2. the sustained follow-up time \>3 month. 3. TNTL single or combined treatment time \>3 month. 4. Chinese ethnicity.

Exclusion criteria

1. the medical record information is not original and available. 2. lactating or pregnant. 3. diagnosis of heart failure, acute myocardial infarction, stroke, or serious injuries. 4. any other conditions not suitable for trial as evaluated by the physician in charge.

Design outcomes

Primary

Measure	Time frame	Description
The Changing (%) of Blood Glucose Level and Glycosylated Hemoglobin Level from Baseline	At least 3 months	The Changing (%) of Blood Glucose Level (mmol/L) and Glycosylated Hemoglobin Level (%) from Baseline (start using Tang Ning Tong Luo capsule) in recruited Type 2 diabetes patients.

Secondary

Measure	Time frame	Description
The Number of Participants with Adverse Events Using Tangning Tongluo Capsule	At least 3 months	The Number of Participants with Adverse Events Using Tangning Tongluo Capsule in the Treatment ofType II Diabetes

Other

Measure	Time frame	Description
Number of adverse events in recruited patients.	At least 3 months	Number of adverse events in recruited patients.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026